Vagina tissue biopsy - Small <1cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Histology of vaginal lesion.

₹296₹423

30% OFF

Vagina Tissue Biopsy - Small <1cm

Why is it done?
- A vaginal tissue biopsy is a diagnostic procedure that involves collecting a small sample of tissue from the vagina for microscopic examination and pathological analysis
- To identify or diagnose vaginal infections, including persistent or recurrent fungal, bacterial, or viral infections not responding to standard treatment
- To evaluate abnormal vaginal bleeding, excessive bleeding during menstruation, or post-menopausal bleeding
- To assess suspicious lesions, ulcers, discoloration, or abnormal growths visible on the vaginal wall
- To diagnose or rule out sexually transmitted infections (STIs) such as herpes simplex virus or human papillomavirus (HPV)
- To evaluate chronic vulvovaginal pain, burning, or itching of unknown etiology
- To detect precancerous or cancerous changes in vaginal epithelium
- To investigate abnormal Pap smear results or cervical/vaginal cytology findings
- Typically performed during gynecological examination when clinical signs warrant tissue-level diagnosis or when less invasive tests have been inconclusive
Normal Range
- Negative/Normal Result: Normal squamous epithelium with intact epithelial lining, absence of malignancy, inflammation, or significant pathological changes. Normal vaginal flora may be present.
- Findings Reported Include: Tissue composition, cellular structure, presence or absence of inflammation, infection type, abnormal cells or dysplasia, keratinization patterns
- Negative for: Malignancy, dysplasia, specific infections, neoplastic changes
- Positive/Abnormal Results May Include: Evidence of infection (fungal, bacterial, viral), inflammatory cells, dysplasia or carcinoma in situ, invasive malignancy, atypical cells, specific STI identification
- Classification System: Results may be categorized using the Bethesda System or similar pathological classification systems for consistency and standardization
Interpretation
- Benign Findings: Normal epithelial tissue without dysplasia or malignancy. May show benign inflammatory response or normal commensals. Reassuring for lack of serious pathology.
- Infectious Processes: Identification of causative organisms (Candida species, Trichomonas vaginalis, herpes simplex virus, bacterial species) guides specific antimicrobial therapy. Chronic or atypical infections may suggest immunosuppression.
- Inflammatory Changes: Increased inflammatory cell infiltrate may indicate active infection, irritant or allergic response, or systemic inflammatory conditions. Severity correlates with clinical symptoms.
- Low-Grade Squamous Intraepithelial Lesion (LSIL): Mild dysplasia usually associated with HPV infection. Often regresses spontaneously but requires monitoring and follow-up. Generally does not progress to malignancy.
- High-Grade Squamous Intraepithelial Lesion (HSIL): Moderate to severe dysplasia with significant risk of malignant transformation. Requires immediate follow-up, possible colposcopy, and potential therapeutic intervention.
- Carcinoma in Situ: Full-thickness dysplasia without invasion. Precancerous lesion with high malignancy potential. Requires immediate intervention, typically surgical excision.
- Invasive Malignancy: Presence of malignant cells invading through basement membrane. Requires urgent oncologic consultation, staging, and comprehensive treatment planning including surgery, radiation, and/or chemotherapy.
- Factors Affecting Interpretation: Biopsy location and sampling adequacy, time of collection in menstrual cycle, patient's hormonal status, history of previous treatments, concurrent medications, immunosuppression status, and presence of multiple pathologies
Associated Organs
- Primary Organ System: Female reproductive system, specifically the vagina and lower female genital tract
- Related Anatomic Structures: Cervix, vulva, uterus, and lower urinary tract may be concurrently affected in infectious or neoplastic processes
- Vaginal Infections Associated with Abnormal Results: Candidal vulvovaginitis, bacterial vaginosis, trichomoniasis, herpes simplex vaginitis, cytomegalovirus infection, and other opportunistic infections
- Neoplastic and Dysplastic Conditions: HPV-related changes (condyloma acuminatum), vaginal intraepithelial neoplasia (VAIN), squamous cell carcinoma, melanoma, adenocarcinoma, and other malignancies
- Inflammatory and Autoimmune Conditions: Lichen sclerosus, lichen planus, pemphigoid, Behçet's disease, and other systemic inflammatory disorders affecting genital tissue
- Potential Complications from Abnormal Findings: Progression to invasive malignancy if dysplasia untreated, pelvic inflammatory disease from ascending infection, compromise of fertility, sexual dysfunction, systemic spread of oncologic disease, and psychological impact of cancer diagnosis
- Impact on Adjacent Tissues: Infection or malignancy can extend to cervix, bladder, rectum, and pelvic structures, necessitating broader imaging and evaluation
Follow-up Tests
- For Infectious Findings: Repeat vaginal cultures or molecular testing after treatment completion to confirm eradication. Sexually transmitted infection panel if HSV or other STIs identified. Testing of sexual partners if indicated.
- For LSIL or Low-Grade Dysplasia: Repeat Pap smear or vaginal cytology in 3-6 months. HPV testing/reflex testing. Colposcopy may be recommended depending on guidelines. Annual or biennial screening until regression confirmed.
- For HSIL or Severe Dysplasia: Urgent colposcopy with possible excisional procedures. Gynecologic oncology referral. Follow-up colposcopy at 3-6 months post-treatment. Regular surveillance cytology for minimum of 25 years.
- For Carcinoma in Situ: Oncology consultation. Imaging studies (MRI, CT, or PET scan) for staging assessment. Possible wider excision or definitive surgical treatment. Quarterly follow-up examination.
- For Invasive Malignancy: Urgent oncology referral. Comprehensive staging studies (CT, MRI, PET imaging, and possibly positron emission tomography). Assessment for distant metastases. Treatment planning for surgery, radiation therapy, and/or chemotherapy. Multidisciplinary tumor board review.
- Complementary and Related Tests: HPV DNA/RNA testing by PCR or hybrid capture methods. Pap smear or liquid-based cytology for surveillance. Cervical biopsy if cervical involvement. Vulvar biopsy if vulvar lesions present. Anorectal screening if indicated.
- Baseline Health Assessment: Complete blood count, metabolic panel, and human immunodeficiency virus (HIV) testing if malignancy or recurrent infections identified, as immunosuppression impacts prognosis.
- Monitoring Frequency: Varies from every 3 months (severe dysplasia) to annual surveillance (post-treatment monitoring) to lifelong follow-up for malignancy survivors based on diagnosis and treatment received
Fasting Required?
- Fasting Required: No - Fasting is not required for a vaginal tissue biopsy. This is a localized tissue collection procedure with no impact on nutritional status.
- Pre-Procedure Preparation: Avoid douching for at least 24 hours before the procedure. Do not use vaginal medications, creams, or lubricants for 24 hours prior unless specifically instructed by physician. Empty bladder before appointment for comfort.
- Timing Considerations: Best performed after menstrual period ends but before ovulation for optimal tissue visibility. Avoid scheduling during heavy menstrual flow. Schedule at least 2 weeks after any vaginal treatment or medication completion.
- Medications: No medications need to be withheld. Continue all systemic medications as scheduled. Inform provider of anticoagulant use (warfarin, apixaban, dabigatran, or similar agents) as these may increase bleeding risk during biopsy.
- Anesthesia: Local anesthesia (topical lidocaine or similar) may be applied to biopsy site for discomfort. General anesthesia is not required for this minor office procedure.
- Patient Comfort Measures: Wear comfortable, easily removable clothing. Discuss anxiety or concerns with provider beforehand. Deep breathing techniques help with relaxation during procedure. Have someone available for transportation if preferred, though not typically required.
- Post-Procedure Instructions: Avoid douching, tampons, and sexual intercourse for 48-72 hours after biopsy. Minimal vaginal spotting is normal; report heavy bleeding. Use acetaminophen for pain; avoid NSAIDs if bleeding is a concern. Normal activities can resume after 24-48 hours.

How our test process works!